Themis Medicare, NFL Biosciences partner on smoking cessation candidate NFL-101

Indian pharmaceutical company Themis Medicare has joined hands with French biotech company NFL Biosciences to develop NFL-101, a drug candidate for smoking cessation for the ... Read More